Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2020 2
2021 8
2022 5
2023 7
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
Grillo S, Pujol M, Miró JM, López-Contreras J, Euba G, Gasch O, Boix-Palop L, Garcia-País MJ, Pérez-Rodríguez MT, Gomez-Zorrilla S, Oriol I, López-Cortés LE, Pedro-Botet ML, San-Juan R, Aguado JM, Gioia F, Iftimie S, Morata L, Jover-Sáenz A, García-Pardo G, Loeches B, Izquierdo-Cárdenas Á, Goikoetxea AJ, Gomila-Grange A, Dietl B, Berbel D, Videla S, Hereu P, Padullés A, Pallarès N, Tebé C, Cuervo G, Carratalà J; SAFO study group. Grillo S, et al. Nat Med. 2023 Oct;29(10):2518-2525. doi: 10.1038/s41591-023-02569-0. Epub 2023 Oct 2. Nat Med. 2023. PMID: 37783969 Free PMC article. Clinical Trial.
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Int J Antimicrob Agents. 2025 Oct;66(4):107563. doi: 10.1016/j.ijantimicag.2025.107563. Epub 2025 Jul 1. Int J Antimicrob Agents. 2025. PMID: 40609707
Impact of a Primary Care Antimicrobial Stewardship Program on Bacterial Resistance Control and Ecological Imprint in Urinary Tract Infections.
Jover-Sáenz A, Ramírez-Hidalgo M, Bellés Bellés A, Ribes Murillo E, Batlle Bosch M, Cayado Cabanillas J, Garrido-Calvo S, Gracia Vilas MI, Gros Navés L, Javierre Caudevilla MJ, Mari López A, Montull Navarro L, Ortiz Valls M, Terrer Manrique G, Vaqué Castilla P, Ichart Tomás JJ, Justribó Sánchez E, Andreu Mayor E, Carrera Guiu J, Martorell Solé R, Pallàs Satué S, Saura Codina M, Vena Martínez A, Albalat Samper JM, Cano Marrón S, Chacón Domínguez I, Escuin DR, Estadella Servalls MJ, Figueres Farreny AM, Minguet Vidal S, Montaña Esteban LM, Otal Bareche J, Pallerola Planes M, Pujol Aymerich F, Rodríguez Garrocho A, Solé Curcó A, Toribio Redondo F, Urgelés Castillón MC, Valgañon Palacios J, Torres-Puig-Gros J, The P-Ilehrda Group, On Behalf Of Translational Research Group On Infectious Diseases Of Lleida Head Group Tridle-IRBLleida. Jover-Sáenz A, et al. Among authors: belles belles a. Antibiotics (Basel). 2022 Dec 8;11(12):1776. doi: 10.3390/antibiotics11121776. Antibiotics (Basel). 2022. PMID: 36551433 Free PMC article.
Effects of a Primary Care Antimicrobial Stewardship Program on Meticillin-Resistant Staphylococcus aureus Strains across a Region of Catalunya (Spain) over 5 Years.
Jover-Sáenz A, Ramírez-Hidalgo M, Bellés Bellés A, Ribes Murillo E, Batlle Bosch M, Ribé Miró A, Mari López A, Cayado Cabanillas J, Piqué Palacín N, Garrido-Calvo S, Ortiz Valls M, Gracia Vilas MI, Gros Navés L, Javierre Caudevilla MJ, Montull Navarro L, Bañeres Argiles C, Vaqué Castilla P, Ichart Tomás JJ, Saura Codina M, Andreu Mayor E, Martorell Solé R, Vena Martínez A, Albalad Samper JM, Cano Marrón S, Soler Elcacho C, Rodríguez Garrocho A, Terrer Manrique G, Solé Curcó A, Escuin DR, Estadella Servalls MJ, Figueres Farreny AM, Montaña Esteban LM, Sanz Borrell L, Morales Valle A, Pallerola Planes M, Hamadi A, Pujol Aymerich F, Toribio Redondo F, Urgelés Castillón MC, Valgañon Palacios J, Olivart Parejo M, Torres-Puig-Gros J, The P-Ilehrda Group, On Behalf Of Clinical Microbiology And Antibiotic Resistance Group-IRBLleida-. Jover-Sáenz A, et al. Among authors: belles belles a. Antibiotics (Basel). 2024 Jan 18;13(1):92. doi: 10.3390/antibiotics13010092. Antibiotics (Basel). 2024. PMID: 38247651 Free PMC article.
Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
Mama OM, Aspiroz C, Lozano C, Ruiz-Ripa L, Azcona JM, Seral C, Cercenado E, López-Cerero L, Palacian P, Belles-Belles A, Berdonces P, Siller M, Aguirre-Quiñonero A, Zarazaga M, Torres C; Spanish Study Group of Clinical S. aureus CC398. Mama OM, et al. Among authors: belles belles a. J Antimicrob Chemother. 2021 Sep 15;76(10):2519-2527. doi: 10.1093/jac/dkab208. J Antimicrob Chemother. 2021. PMID: 34245259
Fungal corneal abscess caused by Exophiala dermatitidis.
Mormeneo Bayo S, Bellés Bellés A, Prats Sánchez I, López González E, Aramburu Arnuelos J, Bernet Sánchez A, García González M. Mormeneo Bayo S, et al. Among authors: belles belles a. Rev Esp Quimioter. 2023 Aug;36(4):425-426. doi: 10.37201/req/133.2022. Epub 2023 Apr 20. Rev Esp Quimioter. 2023. PMID: 37079708 Free PMC article. No abstract available.
Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage.
Roca-Grande J, Mir-Cros A, Muñoz-Almagro C, Lung M, Bellés-Bellés A, Càmara J, Cercenado E, Galán-Ladero MÁ, Martín-Nalda A, Moreno-Mingorance A, Navarro de la Cruz D, Orellana MÁ, Palop B, Pérez-Argüello A, Puigsech-Boixeda G, Quesada MD, Rivera A, Rodriguez-Fernandez A, Ruiz de Gopegui E, Sarvisé C, Soler-Garcia A, Viñado B, Larrosa N, González-López JJ; GE-EMIE Study Team. Roca-Grande J, et al. Among authors: belles belles a. Emerg Microbes Infect. 2025 Dec;14(1):2482696. doi: 10.1080/22221751.2025.2482696. Epub 2025 Mar 27. Emerg Microbes Infect. 2025. PMID: 40105365 Free PMC article.
27 results